Answer
Revolade (eltrombopag olamine) is not recommended during pregnancy; human pregnancy data are absent or limited, animal studies have shown reproductive toxicity, and the potential risk to humans is unknown.
Sources for this answer
- Revolade film-coated tabletsNovartis Pharmaceuticals UK Ltd · emc · SmPC §4.6 Fertility, pregnancy and lactation · Version 28Document updated
Sources checked